trial · primary record
Felzartamab
Microvascular Inflammation
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 81 |
| Primary completion | 2028-02-10 |
| Primary endpoint | Part A: Percentage of Participants Who Achieve Biopsy-proven Histologic Resolution (BPHR) |
| Registry ID | NCT07219043 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:11.131Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07219043
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Felzartamab · compound